Vinge Logotype
SvenskaEnglish 18D7E0DE-2035-40AE-A740-8F45A358A8F4 Login
  1. Home
  2. Mandates
  3. Vinge advises Babcock & Wilcox Völund
Mandate

Vinge advises Babcock & Wilcox Völund

January 15, 2010

Vinge has advised Babcock & Wilcox Völund in connection with the acquisition of Götaverken Miljö AB from the Swedish Sixth AP Fund (Sw. Sjätte AP-Fonden). Götaverken Miljö AB supplies solutions within flue-gas cleaning and energy recycling to incineration plants for household waste, industrial waste and risk classified waste.

Vinge’s team consisted of Patrik Forslund, Stefan de Hevesy, Anders Frick and Astrid Öfverholm. Oskar Löthberg and Anna Möller provided intellectual property law advice and employment law advice was provided by Åsa Gotthardsson and Philip Watson.

Related

Vinge advises Egetis Therapeutics in connection with ANI Pharmaceuticals’ public cash offer

 On 5 November 2026, ANI Pharmaceuticals, Inc., a U.S. biopharmaceutical company listed on The Nasdaq Global Market, announced a recommended public cash offer to the shareholders of Egetis Therapeutics AB (publ) and to the holder of Egetis’ convertible loan and warrants to tender all shares, the convertible loan and the warrants in Egetis to ANI. The total value of the offer amounts to approximately SEK 5,304 million.
November 10, 2026

Vinge has advised Xspray Pharma in connection with its rights issue

 Vinge has advised Xspray Pharma AB (publ) in connection with a rights issue of approximately SEK 90 million before transaction costs, with an over-allotment issue of approximately SEK 72 million.
November 09, 2026

Vinge advises SenzaGen on its acquisition of Alcyomics

 SenzaGen AB (publ) has acquired Alcyomics Ltd. The transaction is being financed through a combination of existing cash and a directed issue of convertible bonds.
November 09, 2026